Pharmacokinetics of ferric pyrophosphate citrate administered via dialysate and intravenously to pediatric patients on chronic hemodialysis

BACKGROUND: Iron deficiency is a common cause of anemia in pediatric patients with hemodialysis-dependent chronic kidney disease (CKD-5HD). Ferric pyrophosphate citrate (FPC, Triferic®) donates iron directly to transferrin, bypassing the reticuloendothelial system and avoiding iron sequestration. Ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Pratt, Raymond D., Grimberg, Sarah, Zaritsky, Joshua J., Warady, Bradley A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153505/
https://www.ncbi.nlm.nih.gov/pubmed/30003313
http://dx.doi.org/10.1007/s00467-018-4014-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153505/
https://www.ncbi.nlm.nih.gov/pubmed/30003313
http://dx.doi.org/10.1007/s00467-018-4014-3

Ejemplares similares